Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists identify novel gene driving the growth and survival of melanoma cells

07.07.2005


Overcopied pigment-cell gene may serve as target for future drug attacks



A team of researchers led by scientists at Dana-Farber Cancer Institute have discovered a genetic abnormality in the cells of some advanced melanoma patients that worsens their chances of survival, but also might be a target of future drug attack against the dangerous skin cancer.

Dana-Farber’s Levi Garraway, MD, PhD, and William Sellers, MD, the paper’s first and senior authors, and their colleagues will report their findings in the July 7 issue of the journal Nature.


"By pinpointing the abnormally multiplied MITF oncogene, we may be able to develop better diagnostic and prognostic tools as well as provide a target for highly specific therapies for metastatic melanoma patients who have this overcopied gene," explains Sellers, who also holds an appointment with the Broad Institute of Harvard and MIT and with Harvard Medical School.

Melanoma accounts for just six percent of diagnosed skin cancer cases in the United States, but it is the deadliest, causing three quarters of all skin cancer related deaths. The American Cancer Society estimates that 7,700 melanoma patients will die this year.

Caused mainly by sun exposure, melanoma has been increasing rapidly over the past several decades. Nearly 60,000 new cases are expected in 2005. Most cases caught early can be cured, but if melanoma cells penetrate the skin deeply, the cancer is highly prone to spread with life-threatening consequences despite treatment with surgery, chemotherapy and radiation.

The researchers used single nucleotide polymorphism (SNP) array technology, which focuses on the building blocks of individual genes, to identify regions of chromosomes where genes were either left out or multiplied over and over – mistakes that are often associated with cancer.

In studying cells from primary and metastatic melanoma tumors, the scientists observed as many as 13 extra copies of the MITF gene in 10 percent of primary melanomas and 21 percent of metastatic tumors.

When they checked the treatment outcomes of the patients from whom the tumor samples were taken, researchers found poorer 5-year survival rates among patients whose metasases contained the overcopied or "amplified" MITF gene.

Abnormal amplification of the MITF gene was found to be associated with other genetic changes as well. They included mutations in a gene, BRAF, previously found in melanoma cells, and silencing of p16, a "tumor-suppressor" gene that normally keeps cells from dividing too rapidly and causing cancer.

Aside from its clinical potential, the scientists say the finding advances the understanding of cancer: It highlights a previously unknown mechanism by which a tumor can become "addicted" to an oncogene that, in its normal form, plays a role in developing and maintaining tissues. That is, the tumor cannot survive without a high level of production of the oncogene’s protein. Dana-Farber’s David E. Fisher, MD, PhD, an author on the paper, has previously shown that the MITF gene normally regulates the development of the skin’s pigment-producing cells, or melanocytes. It appears the extra dosage of MITF protein spurs the melanocytes into malignant growth and maintains the tumor’s survival.

"We might be able to treat these metastatic melanomas by targeting the MITF gene or protein, alone or in combination with drugs that block BRAF," says Sellers. "We know that when MITF activity is reduced, melanoma cells become more vulnerable to chemotherapy drugs." However, he said, MITF is a "transcription factor" that controls the expression of other genes, and these factors have proven difficult to manipulate with drugs.

The papers other co-authors are Hans R. Widlund, PhD, Dana-Farber; Mark A. Rubin, MD, Danny A. Milner, MD, Scott R. Granter, MD, and Charles Lee, PhD, Brigham and Women’s Hospital; Gad A. Getz, Broad Institute of Harvard and MIT; David L. Rimm, MD, PhD, and Aaron Berger, Yale University School of Medicine; Sridhar Ramaswamy, MD, Broad Institute of Harvard and MIT and Massachusetts General Hospital; Jinyan Du, PhD, Dana-Farber and Broad Institute of Harvard and MIT; Stephan N. Wagner, MD, Medical University of Vienna in Austria; Cheng Li, PhD, Dana-Farber and Harvard School of Public Health; Todd R. Golub, MD, and Matthew Meyerson, MD, Dana-Farber, Brigham and Women’s Hospital and the Broad Institute of Harvard and MIT.

Bill Schaller | EurekAlert!
Further information:
http://www.dfci.harvard.edu

More articles from Life Sciences:

nachricht NYSCF researchers develop novel bioengineering technique for personalized bone grafts
18.07.2018 | New York Stem Cell Foundation

nachricht Pollen taxi for bacteria
18.07.2018 | Technische Universität München

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Machine-learning predicted a superhard and high-energy-density tungsten nitride

18.07.2018 | Materials Sciences

NYSCF researchers develop novel bioengineering technique for personalized bone grafts

18.07.2018 | Life Sciences

Why might reading make myopic?

18.07.2018 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>